Lexaria Bioscience Corp Stock Alpha and Beta Analysis
| LEXXW Stock | USD 0.25 0 0.44% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Lexaria Bioscience Corp. It also helps investors analyze the systematic and unsystematic risks associated with investing in Lexaria Bioscience over a specified time horizon. Remember, high Lexaria Bioscience's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Lexaria Bioscience's market risk premium analysis include:
Beta (1.26) | Alpha (0.96) | Risk 13.16 | Sharpe Ratio (0.11) | Expected Return (1.46) |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Lexaria |
Lexaria Bioscience Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Lexaria Bioscience market risk premium is the additional return an investor will receive from holding Lexaria Bioscience long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Lexaria Bioscience. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Lexaria Bioscience's performance over market.| α | -0.96 | β | -1.26 |
Lexaria Bioscience expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Lexaria Bioscience's Buy-and-hold return. Our buy-and-hold chart shows how Lexaria Bioscience performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Lexaria Bioscience Market Price Analysis
Market price analysis indicators help investors to evaluate how Lexaria Bioscience stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Lexaria Bioscience shares will generate the highest return on investment. By understating and applying Lexaria Bioscience stock market price indicators, traders can identify Lexaria Bioscience position entry and exit signals to maximize returns.
Lexaria Bioscience Return and Market Media
The median price of Lexaria Bioscience for the period between Wed, Dec 4, 2024 and Tue, Mar 4, 2025 is 0.62 with a coefficient of variation of 35.81. The daily time series for the period is distributed with a sample standard deviation of 0.21, arithmetic mean of 0.58, and mean deviation of 0.18. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Revolutionizing Healthcare Lexaria Highlights Expanding Therapeutic Benefits of GLP-1 Drugs | 11/26/2024 |
2 | LEXX Enterprise Value 38.78 Mil - GuruFocus.com | 12/06/2024 |
3 | Acquisition by Mckechnie William Edward of 5000 shares of Lexaria Bioscience at 0.87 subject to Rule 16b-3 | 12/16/2024 |
4 | Esteemed Harvard Medical School Professor Dr. Michael Gibson Appointed Chief Medical Advisor at Lexaria Bioscience | 12/17/2024 |
5 | H.C. Wainwright maintains Buy rating on Lexaria Bioscience stock By Investing.com - Investing.com Nigeria | 12/23/2024 |
6 | Acquisition by Baxter Nicholas W of 110000 shares of Lexaria Bioscience at 0.1 subject to Rule 16b-3 | 01/03/2025 |
7 | Acquisition by Baxter Nicholas W of 5000 shares of Lexaria Bioscience at 7.08 subject to Rule 16b-3 | 01/08/2025 |
8 | Lexaria Bioscience Corp. Reports Earnings Results for the First Quarter Ended November 30, 2024 - Marketscreener.com | 01/10/2025 |
9 | Disposition of 50000 shares by Spissinger Allan Horst of Lexaria Bioscience at 0.37 subject to Rule 16b-3 | 01/17/2025 |
10 | Lexaria Initiates Groundbreaking Biodistribution Study for DehydraTECH GLP-1 - TipRanks | 02/06/2025 |
11 | Disposition of 400000 shares by John Docherty of Lexaria Bioscience at 1.53 subject to Rule 16b-3 | 02/24/2025 |
About Lexaria Bioscience Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Lexaria or other stocks. Alpha measures the amount that position in Lexaria Bioscience Corp has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2022 | 2023 | 2024 | 2025 (projected) | Days Sales Outstanding | 282.77 | 121.44 | 26.35 | 25.03 | PTB Ratio | 2.28 | 6.03 | 54.87 | 57.61 |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Lexaria Bioscience in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Lexaria Bioscience's short interest history, or implied volatility extrapolated from Lexaria Bioscience options trading.
Build Portfolio with Lexaria Bioscience
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for Lexaria Stock Analysis
When running Lexaria Bioscience's price analysis, check to measure Lexaria Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lexaria Bioscience is operating at the current time. Most of Lexaria Bioscience's value examination focuses on studying past and present price action to predict the probability of Lexaria Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lexaria Bioscience's price. Additionally, you may evaluate how the addition of Lexaria Bioscience to your portfolios can decrease your overall portfolio volatility.